Elevation Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.17
|
|
Average Rating
|
3.80
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.94
|
0.00
|
0.94
|
100.00%
|
|
2022-12-31
|
-0.77
|
0.00
|
0.77
|
100.00%
|
|
2022-09-30
|
-1.30
|
-1.67
|
-0.37
|
-28.46%
|
|
2022-06-30
|
-0.79
|
-0.86
|
-0.07
|
-8.86%
|
|
2022-03-31
|
-0.50
|
-0.74
|
-0.24
|
-48.00%
|
|
2021-12-31
|
-0.59
|
-0.41
|
0.18
|
30.51%
|
|
2021-09-30
|
-0.38
|
-0.53
|
-0.15
|
-39.47%
|
|
2021-06-30
|
-2.82
|
-4.84
|
-2.02
|
-71.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.27
|
|
2021-12-31
|
-6.69
|
|
2020-12-31
|
-1.50
|
|
2019-12-31
|
-0.59
|